ALS Invest 1 B.V. is 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX). They have made 1 open-market trade across 1 company since 2022, most recently 2022-07-06.
CIK 0001920501
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMLX | 5,895,280 | $155.4M |
Shares reported on the most recent Form 4, priced at the 2022-07-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMLX | SELL | 2022-07-06 | 2022-07-08 | $20.70 | $2.5M | +1.5% | +12.6% | +48.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.